OrsoBio

Tanai Therapeutics

This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

eracal

This biotechnology company develops anti-obesity medicines and appetite modulators for patients with metabolic disorders.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Ambrosia Biosciences

This drug discovery company develops orally delivered small-molecule therapies for obesity and metabolic disorders for patients requiring alternatives to injectable treatments.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.